Accendra Health, Inc. ACH
0.20 USD -0.09 (-31.53%)
At closeNov 6, 2026, 4:02 PM EST
0.21 0.00 +2.20%
After hours · Nov 6, 4:02 PM ET
0.2007 Day range 0.245
0.19 52-week range 4.69
- YTD
- -92.71%
- 1 year
- -93.46%
News
seekingalpha.com Accendra Health, Inc. (ACH) Q3 2026 Earnings Call Transcript Accendra Health, Inc. ( ACH ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants Will Parrish - VP of Strategy, Corporate Development, & IR Kenneth Gardner-Smith - President, CEO…
benzinga.com Accendra Health Q3 2026 Earnings Call Transcript Accendra Health (NYSE:ACH) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers TransMedics Group (NASDAQ:TMDX) stock rose 17.6% to $81.16 during Thursday's after-market session. The company's market cap stands at $2.5 billion. The company's, Q3 earnings came out today.
benzinga.com Accendra Health Affirms FY2026 Sales Guidance of $2.450B-$2.550B vs $2.491B Est Accendra Health (NYSE:ACH) affirms FY2026 sales outlook from $2.450 billion-$2.550 billion to $2.450 billion-$2.550 billion vs $2.491 billion estimate.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 16.2% to $4.67 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million. Cerus…
benzinga.com Accendra Health Extends $150M Receivables Purchase Agreement To October 2029 With Its Size Unchanged The amendment, among other things, extends the Scheduled Termination Date of the facility to October 2029, and the $150 million size of the Receivables Sale Program is unchanged."We are pleased to…
businesswire.com Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029 RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it executed an amendment to its Receivables Purchase Agreement (the “Receivables Sale Program”)…
businesswire.com Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders' Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 27, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Pharvaris (NASDAQ:PHVS) stock moved upwards by 19.4% to $36.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.0 billion. CalciMedica (NASDAQ:CALC)…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 13.3% to $0.55 during Wednesday's after-market session. Impact BioMedical (AMEX:IBO) stock rose 10.77% to $3.77. The company's market cap…- benzinga.com Accendra Health Names Kenneth Gardner-Smith as Next President and CEO; Expected To Assume the Role Early in Q4 of 2026, succeeding Edward Pesicka Chief Commercial OfficerAccendra Health also today named Scott Lloyd to the role of Chief Commercial Officer, effective October 5, 2026. The Company created the position to bring commercial strategy,…
benzinga.com Accendra Health Appoints Kenneth Gardner-Smith As President And CEO, Succeeding Edward Pesicka Gardner-Smith to Succeed Ed Pesicka Following Previously Announced RetirementCompany Announces Scott Lloyd as Chief Commercial OfficerAccendra Health, Inc. (NYSE:ACH) (the "Company") today named…
benzinga.com Accendra Health Updates Capital Plans; Nets $45M From Non-Core Asset Sales And Sets CEO Succession Timeline For September Accendra Health (the "Company") is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer.Given recent market conditions, the Company…
benzinga.com UBS Maintains Neutral on Accendra Health, Lowers Price Target to $1.5 UBS analyst Kevin Caliendo maintains Accendra Health (NYSE:ACH) with a Neutral and lowers the price target from $4.5 to $1.5.- benzinga.com Citigroup Downgrades Accendra Health to Neutral, Lowers Price Target to $1.5 Citigroup analyst Daniel Grosslight downgrades Accendra Health (NYSE:ACH) from Buy to Neutral and lowers the price target from $4.5 to $1.5.
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Jin Medical International (NASDAQ:ZJYL) shares rose 58.1% to $3.4 during Monday's regular session. The market value of their outstanding shares is at $16.8 million. As per the press release,…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-market session. The company's market cap stands at $16.8 million. As per the news, the H1 earnings report…- benzinga.com Accendra Health Adopts Section 382 Rights Agreement To Protect Long-Term Shareholder Value By Preserving Its Net Operating Loss Carryforwards A company generally experiences an ownership change if the percentage of the value of its stock owned by certain "5-percent shareholders," as such term is defined in Section 382 of the Code,…
- benzinga.com Accendra Health Lowers FY2026 Sales Guidance from $2.550B-$2.650B to $2.450B-$2.550B vs $2.574B Est Accendra Health (NYSE:ACH) lowers FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.450 billion-$2.550 billion vs $2.574 billion estimate.
- benzinga.com Accendra Health’s President And CEO Edward Pesicka Plans To Retire By 2026 End Accendra Health, Inc. (NYSE:ACH) (the Company) today announced that President and Chief Executive Officer Edward A. Pesicka has informed the Board of Directors of his plan to retire by the end of…
- benzinga.com Citigroup Maintains Buy on Accendra Health, Lowers Price Target to $4.5 Citigroup analyst Daniel Grosslight maintains Accendra Health (NYSE:ACH) with a Buy and lowers the price target from $5 to $4.5.
- benzinga.com UBS Maintains Neutral on Accendra Health, Raises Price Target to $4.5 UBS analyst Kevin Caliendo maintains Accendra Health (NYSE:ACH) with a Neutral and raises the price target from $3 to $4.5.
- benzinga.com Citigroup Maintains Buy on Accendra Health, Raises Price Target to $5 Citigroup analyst Daniel Grosslight maintains Accendra Health (NYSE:ACH) with a Buy and raises the price target from $3.25 to $5.
- benzinga.com Baird Maintains Outperform on Accendra Health, Raises Price Target to $6 Baird analyst Eric Coldwell maintains Accendra Health (NYSE:ACH) with a Outperform and raises the price target from $5 to $6.
- benzinga.com Accendra Health Affirms FY2026 Sales Guidance of $2.550B-$2.650B vs $2.590B Est Accendra Health (NYSE:ACH) affirms FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.550 billion-$2.650 billion vs $2.590 billion estimate.
benzinga.com Earnings Scheduled For May 11, 2026 
benzinga.com Leerink Partners Maintains Market Perform on Accendra Health, Lowers Price Target to $2.75 Leerink Partners analyst Michael Cherny maintains Accendra Health (NYSE:ACH) with a Market Perform and lowers the price target from $3 to $2.75.- benzinga.com Accendra Health, Inc. Common Stock Q4 Adj. EPS $0.21 Misses $0.22 Estimate, Sales $708.967M Miss $714.733M Estimate Accendra Health, Inc. Common Stock (NYSE:ACH) reported quarterly earnings of $0.21 per share which missed the analyst consensus estimate of $0.22 by 4.98 percent. This is a 34.38 percent decrease…
- benzinga.com Earnings Scheduled For February 19, 2026
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 550 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 186 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 1043 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 351 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 721 companies achieved new lows for the year.
- benzinga.com 46 Biggest Movers From Yesterday Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share.
benzinga.com 36 Stocks Moving In Tuesday's Mid-Day Session Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results.- benzinga.com 72 Biggest Movers From Yesterday Gainers
- benzinga.com 45 Stocks Moving In Monday's Mid-Day Session Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets.
- benzinga.com 21 Stocks Moving in Monday's Pre-Market Session Gainers Itamar Medical Ltd. (NASDAQ: ITMR) rose 43% to $29.52 in pre-market trading. Zoll Medical said it has signed an agreement to acquire Itamar Medical for $31 per ADS in cash.
- benzinga.com 9 Materials Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com Stocks That Hit 52-Week Highs On Monday This morning 792 companies reached new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Friday On Friday morning, 417 companies achieved new highs for the year.
benzinga.com Stocks That Hit 52-Week Highs On Thursday Thursday morning saw 321 companies set new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Wednesday Wednesday's morning session saw 275 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday Before 10 a.m. ET on Tuesday, 166 companies hit new 52-week highs.
- benzinga.com 44 Biggest Movers From Yesterday Gainers Chemomab Therapeutics Ltd. (NASDAQ: CMMB) shares jumped 111.5% to close at $55.00 on Thursday.
- benzinga.com Stocks That Hit 52-Week Highs On Thursday Before 10 a.m. ET Thursday, 371 stocks hit new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Monday During Monday's morning trading, 285 companies set new 52-week highs.